Cancer therapy and cardiovascular risk: focus on bevacizumab

Cancer therapy and cardiovascular risk: focus on bevacizumab

Panagiota Economopoulou,1 Athanasios Kotsakis,2 Ioannis Kapiris,3 Nikolaos Kentepozidis3 1Medical Oncology Unit, 2nd Department of Internal Medicine, Attikon University Hospital, Haidari, Athens, 2Department of Medical Oncology, University Hospital of Heraklion, Crete, 3251 Airforce General Hospital...

Full description

Bibliographic Details
Main Authors: Economopoulou P, Kotsakis A, Kapiris I, Kentepozidis N
Format: Article
Language:English
Published: Dove Medical Press 2015-06-01
Series:Cancer Management and Research
Online Access:http://www.dovepress.com/cancer-therapy-and-cardiovascular-risk-focus-on-bevacizumab-peer-reviewed-article-CMAR

Internet

http://www.dovepress.com/cancer-therapy-and-cardiovascular-risk-focus-on-bevacizumab-peer-reviewed-article-CMAR

Similar Items